| scholarly article | Q13442814 |
| P50 | author | Myron M. Levine | Q29564379 |
| Marcela F. Pasetti | Q56380831 | ||
| Karen L Kotloff | Q63214788 | ||
| P2093 | author name string | Franklin R Toapanta | |
| Marcelo B Sztein | |||
| Eileen M Barry | |||
| Jakub K Simon | |||
| P2860 | cites work | Elucidation of seventeen human peripheral blood B-cell subsets and quantification of the tetanus response using a density-based method for the automated identification of cell populations in multidimensional flow cytometry data | Q24605194 |
| High endothelial venules (HEVs): specialized endothelium for lymphocyte migration | Q28288508 | ||
| Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans | Q29616204 | ||
| Characterization of B-cell epitopes on IpaB, an invasion-associated antigen of Shigella flexneri: identification of an immunodominant domain recognized during natural infection | Q33608118 | ||
| Expression of homing receptors on IgA1 and IgA2 plasmablasts in blood reflects differential distribution of IgA1 and IgA2 in various body fluids | Q33725110 | ||
| Global burden of Shigella infections: implications for vaccine development and implementation of control strategies | Q33749510 | ||
| Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humans | Q33768258 | ||
| Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection | Q34117580 | ||
| Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults | Q34120926 | ||
| Intestinal IgA synthesis: regulation of front-line body defences | Q34168492 | ||
| Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization | Q34205800 | ||
| Heterogeneity of multifunctional IL-17A producing S. Typhi-specific CD8+ T cells in volunteers following Ty21a typhoid immunization | Q34297117 | ||
| Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study | Q34345075 | ||
| Impact of oral typhoid vaccination on the human gut microbiota and correlations with s. Typhi-specific immunological responses | Q34700862 | ||
| Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates. | Q34809879 | ||
| Systems biology of vaccination for seasonal influenza in humans | Q35118722 | ||
| Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking | Q35208814 | ||
| Plasma-cell homing | Q35549150 | ||
| Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. | Q41541656 | ||
| Functionally Distinct Subpopulations of CpG-Activated Memory B Cells. | Q42030999 | ||
| Diverse phosphorylation patterns of B cell receptor-associated signaling in naïve and memory human B cells revealed by phosphoflow, a powerful technique to study signaling at the single cell level | Q42421045 | ||
| Studies on vaccination against bacillary dysentery. 3. Effective oral immunization against Shigella flexneri 2a in a field trial | Q42982958 | ||
| Human immune responses to influenza virus vaccines administered by systemic or mucosal routes | Q45772716 | ||
| Blood-borne human plasma cells in steady state are derived from mucosal immune responses | Q46262153 | ||
| Homing potentials of circulating lymphocytes in humans depend on the site of activation: oral, but not parenteral, typhoid vaccination induces circulating antibody-secreting cells that all bear homing receptors directing them to the gut. | Q50135778 | ||
| Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine | Q50201269 | ||
| Immunogenicity of Ty21a attenuated "Salmonella typhi" given with sodium bicarbonate or in enteric-coated capsules. | Q50212585 | ||
| Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease. | Q50464343 | ||
| Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. | Q51996837 | ||
| Expression of GlyCAM-1, an endothelial ligand for L-selectin, is affected by afferent lymphatic flow. | Q52220993 | ||
| Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells. | Q52940412 | ||
| A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity. | Q54158784 | ||
| Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults. | Q54572055 | ||
| Cloning, expression, and affinity purification of recombinant Shigella flexneri invasion plasmid antigens IpaB and IpaC. | Q54576324 | ||
| Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei | Q67941446 | ||
| Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population | Q68134308 | ||
| Mucosally activated circulating human B cells in diarrhea express homing receptors directing them back to the gut | Q71035571 | ||
| Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media | Q81445405 | ||
| Shigellosis: innate mechanisms of inflammatory destruction of the intestinal epithelium, adaptive immune response, and vaccine development | Q35696566 | ||
| Persistence of diarrheal pathogens is associated with continued recruitment of plasmablasts in the circulation | Q35726077 | ||
| Lymphocyte trafficking across high endothelial venules: dogmas and enigmas | Q35762431 | ||
| Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans | Q35826280 | ||
| Peroral ciprofloxacin therapy impairs the generation of a protective immune response in a mouse model for Salmonella enterica serovar Typhimurium diarrhea, while parenteral ceftriaxone therapy does not. | Q35941385 | ||
| Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans | Q36017715 | ||
| Lymphocyte homing to the gut: attraction, adhesion, and commitment | Q36209695 | ||
| Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis | Q36365336 | ||
| The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells | Q36369860 | ||
| Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival? | Q36703588 | ||
| Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains | Q36720620 | ||
| Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road | Q36844719 | ||
| Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a. | Q36920244 | ||
| Indirect measurement of intestinal immune responses to an orally administered attenuated bacterial vaccine | Q36945363 | ||
| Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides. | Q36966451 | ||
| Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp | Q37010733 | ||
| Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues | Q37044185 | ||
| Circulating human antibody-secreting cells during vaccinations and respiratory viral infections are characterized by high specificity and lack of bystander effect | Q37053088 | ||
| Progress and pitfalls in Shigella vaccine research | Q37105553 | ||
| Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidates | Q37120727 | ||
| Presence of specific immunoglobulin A-secreting cells in peripheral blood after natural infection with Shigella sonnei | Q37125747 | ||
| Key developmental transitions in human germinal center B cells are revealed by differential CD45RB expression | Q37169139 | ||
| Differentiation and homing of IgA-secreting cells | Q37349705 | ||
| Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses | Q37365152 | ||
| Dendritic cells in intestinal homeostasis and disease. | Q37591719 | ||
| Update on mucosal immunoglobulin A in gastrointestinal disease | Q37778711 | ||
| Shigella are versatile mucosal pathogens that circumvent the host innate immune system. | Q37901683 | ||
| Origin and Function of Circulating Plasmablasts during Acute Viral Infections | Q38008373 | ||
| Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208. | Q39146446 | ||
| Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile | Q39252440 | ||
| Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection | Q39822312 | ||
| Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins | Q40105951 | ||
| Plasmablast-derived polyclonal antibody response after influenza vaccination | Q40339871 | ||
| Rotavirus-specific B cells induced by recent infection in adults and children predominantly express the intestinal homing receptor alpha4beta7. | Q40613333 | ||
| Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2 | Q40687041 | ||
| An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination | Q41024287 | ||
| Shigellosis: from molecular pathogenesis of infection to protective immunity and vaccine development | Q41452318 | ||
| Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain | Q41480678 | ||
| Semiquantitative estimation of Shigella antigen-specific antibodies: correlation with disease severity during shigellosis | Q41490859 | ||
| P921 | main subject | attenuated vaccine | Q1810913 |
| P304 | page(s) | 374 | |
| P577 | publication date | 2014-08-20 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans | |
| P478 | volume | 5 |
| Q90621575 | A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization |
| Q93367325 | Diminished B-Cell Response After Repeat Influenza Vaccination |
| Q50652449 | Induction of long term mucosal immunological memory in humans by an oral inactivated multivalent enterotoxigenic Escherichia coli vaccine. |
| Q36051755 | Oral Challenge with Wild-Type Salmonella Typhi Induces Distinct Changes in B Cell Subsets in Individuals Who Develop Typhoid Disease |
| Q37477191 | Shigella Vaccine Development: Finding the Path of Least Resistance |
| Q52657631 | T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans. |
Search more.